In these videos, Sushila Dulal, MD, associate professor of medicine at the University Chicago of Medicine, discusses the latest treatments, state of the pipeline and unmet needs for patients with ...

Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...

Upadacitinib showed promising results in achieving clinical and endoscopic remission in people with moderate to severe Crohn ...

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services ...

Obesity is linked to lower steroid-free clinical remission rates in patients with inflammatory bowel disease, a recent study ...

A substantial proportion of patients with inflammatory bowel disease have avoidant/restrictive food intake disorder even when ...